Cargando…

Telehealth and Screening Strategies in the Diagnosis and Management of Glaucoma

Telehealth has become a viable option for glaucoma screening and glaucoma monitoring due to advances in technology. The ability to measure intraocular pressure without an anesthetic and to take optic nerve photographs without pharmacologic pupillary dilation using portable equipment have allowed gla...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Sze H., Tsai, James C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396962/
https://www.ncbi.nlm.nih.gov/pubmed/34441748
http://dx.doi.org/10.3390/jcm10163452
_version_ 1783744495929524224
author Wong, Sze H.
Tsai, James C.
author_facet Wong, Sze H.
Tsai, James C.
author_sort Wong, Sze H.
collection PubMed
description Telehealth has become a viable option for glaucoma screening and glaucoma monitoring due to advances in technology. The ability to measure intraocular pressure without an anesthetic and to take optic nerve photographs without pharmacologic pupillary dilation using portable equipment have allowed glaucoma screening programs to generate enough data for assessment. At home, patients can perform visual acuity testing, web-based visual field testing, rebound tonometry, and video visits with the physician to monitor for glaucomatous progression. Artificial intelligence will enhance the accuracy of data interpretation and inspire confidence in popularizing telehealth for glaucoma.
format Online
Article
Text
id pubmed-8396962
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83969622021-08-28 Telehealth and Screening Strategies in the Diagnosis and Management of Glaucoma Wong, Sze H. Tsai, James C. J Clin Med Review Telehealth has become a viable option for glaucoma screening and glaucoma monitoring due to advances in technology. The ability to measure intraocular pressure without an anesthetic and to take optic nerve photographs without pharmacologic pupillary dilation using portable equipment have allowed glaucoma screening programs to generate enough data for assessment. At home, patients can perform visual acuity testing, web-based visual field testing, rebound tonometry, and video visits with the physician to monitor for glaucomatous progression. Artificial intelligence will enhance the accuracy of data interpretation and inspire confidence in popularizing telehealth for glaucoma. MDPI 2021-08-04 /pmc/articles/PMC8396962/ /pubmed/34441748 http://dx.doi.org/10.3390/jcm10163452 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Wong, Sze H.
Tsai, James C.
Telehealth and Screening Strategies in the Diagnosis and Management of Glaucoma
title Telehealth and Screening Strategies in the Diagnosis and Management of Glaucoma
title_full Telehealth and Screening Strategies in the Diagnosis and Management of Glaucoma
title_fullStr Telehealth and Screening Strategies in the Diagnosis and Management of Glaucoma
title_full_unstemmed Telehealth and Screening Strategies in the Diagnosis and Management of Glaucoma
title_short Telehealth and Screening Strategies in the Diagnosis and Management of Glaucoma
title_sort telehealth and screening strategies in the diagnosis and management of glaucoma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396962/
https://www.ncbi.nlm.nih.gov/pubmed/34441748
http://dx.doi.org/10.3390/jcm10163452
work_keys_str_mv AT wongszeh telehealthandscreeningstrategiesinthediagnosisandmanagementofglaucoma
AT tsaijamesc telehealthandscreeningstrategiesinthediagnosisandmanagementofglaucoma